No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ORMP240816C5000
- 0.01
- -0.04-80.00%
15min DelayClose Jul 23 15:50 ET
0.05High0.01Low
0.05Open0.05Pre Close60 Volume2.08K Open Interest5.00Strike Price100.00Turnover124.66%IV90.49%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0336Delta0.0885Gamma263.00Leverage Ratio-0.0013Theta0.0001Rho8.83Eff Leverage0.0005Vega
Intraday
- 5D
- Daily
News
Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend
Express News | Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech
Express News | Oramed Pharmaceuticals And Hefei Tianhui Biotech Finalize Joint Venture; JV To Receive Capital Infusion With HTIT Committing $70M In Cash And Oramed Investing $25M In Cash and Stock
Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv
Express News | Oramed Pharmaceuticals Inc: Jv With Chinese Partner, Htit
Express News | Oramed Pharmaceuticals Authorizes $20M Buyback
Comments
$Oramed Pharmaceuticals(ORMP.US$ target price $30.00
1
$Oramed Pharmaceuticals(ORMP.US$ Can Not Short Better No Buy DELETE 🤗👊👍
1
Read more